In early 2026, a dangerous virus began spreading in the Democratic Republic of the Congo. Scientists believe it first appeared in Mongbwalu around February. The threat was hidden for weeks until April 24, when a patient in Ituri province showed severe symptoms. Sadly, this first confirmed patient died four days later.
By mid-May, tests confirmed the illness was the Bundibugyo ebolavirus, known for causing deadly hemorrhagic fevers. Fatality rates for such viruses can range from 25% to 90%. The situation worsened quickly. On May 17, the World Health Organization (WHO) declared it a public health emergency. By mid-June, the virus had spread to other countries. The Democratic Republic of the Congo reported 808 infections and 192 deaths, mostly in Ituri. Neighboring Uganda also confirmed 19 new cases and two deaths.
This region is sadly familiar with Ebola. This is the seventeenth outbreak in the Democratic Republic of the Congo since 1976. The country had only recently ended its last outbreak in December 2025.
Currently, there are no approved vaccines or specific treatments for the Bundibugyo variant. Doctors are testing new treatments, but for now, care focuses on supporting patients with fluids and managing complications.
On June 17, the WHO released its first comprehensive guidelines for treating filovirus infections, including Ebola and Marburg viruses. This new manual offers 16 recommendations based on scientific evidence, prioritizing rapid supportive care to improve patient survival. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighted the guidelines' importance in using science to protect people during health crises. These new strategies provide a crucial tool for medical teams fighting the virus.